All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Prof. Marek Trneny | EBMT 2018 | What were the most interesting results from EBMT?
What were the most interesting results from EBMT?
Educational theme: High-risk patients with lymphoid malignancies
Despite the plethora of regimens and the chemosensitivity of aggressive B-cell lymphomas, many patients fail to respond well to treatment. This article collates expert opinions...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox